MARKET

THMO

THMO

ThermoGenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.390
-0.230
-6.35%
Opening 15:08 11/21 EST
OPEN
3.630
PREV CLOSE
3.620
HIGH
3.630
LOW
3.205
VOLUME
47.17K
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
2.100
MARKET CAP
8.19M
P/E (TTM)
-0.6463
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of THMO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

THMO News

  • ThermoGenesis Holdings Q3 Sales $4.06M Miss $4.8M Estimate
  • Benzinga.1d ago
  • ThermoGenesis Holdings Announces Improved Third Quarter 2019 Financial Results And Provides Corporate Update
  • PR Newswire.1d ago
  • ThermoGenesis Holdings To Postpone Third Quarter 2019 Earnings Release And Conference Call Until Tuesday November 19, 2019
  • PR Newswire.6d ago
  • ThermoGenesis Holdings To Delay Third Quarter 2019 Earnings Release And Conference Call Until Thursday, November 14, 2019
  • PR Newswire.11/12 19:46

More

Industry

Office Equipment
+0.61%
Technology Equipment
-0.69%

Hot Stocks

Name
Price
%Change

About THMO

ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy market.
More

Webull offers Thermogenesis Holdings Inc (THMO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.